AbCellera Biologics Inc.
ABCLNasdaqCIK 1703057HealthcareFiscal year ends Dec 31
Reports and events: 100 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1316:33 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-349353 |
| 2026-08-1007:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-26-000053 |
| 2026-08-0716:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001703057-26-000049 |
| 2026-08-0516:28 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001703057-26-000046 |
| 2026-08-0516:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-26-000044 |
| 2026-07-2911:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001703057-26-000039 |
| 2026-07-0614:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001703057-26-000037 |
| 2026-06-1712:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001703057-26-000035 |
| 2026-06-1212:12 ET | 8-K | 5.07 Shareholder vote results | 0001703057-26-000033 |
| 2026-06-0512:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001703057-26-000031 |
| 2026-05-1116:18 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001703057-26-000028 |
| 2026-05-1116:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-26-000027 |
| 2026-04-2914:07 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001703057-26-000020 |
| 2026-02-2416:38 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001703057-26-000012 |
| 2026-02-2416:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-26-000010 |
| 2026-01-1417:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-26-000003 |
| 2025-12-1814:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-25-000034 |
| 2025-11-2814:20 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001703057-25-000032 |
| 2025-11-1213:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001703057-25-000029 |
| 2025-11-0616:27 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001703057-25-000025 |
| 2025-11-0616:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-25-000024 |
| 2025-09-1012:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001703057-25-000018 |
| 2025-08-0716:36 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001703057-25-000011 |
| 2025-08-0716:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-038927 |
| 2025-06-1313:20 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-031219 |
| 2025-05-3013:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-028529 |
| 2025-05-1417:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-025573 |
| 2025-05-1314:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-025006 |
| 2025-05-0816:21 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-023836 |
| 2025-05-0816:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-023808 |
| 2025-04-2916:27 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001628280-25-020703 |
| 2025-02-2716:24 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-008689 |
| 2025-02-2716:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-008650 |
| 2025-02-1811:56 ET | 8-K | 8.01 Other events | 0001628280-25-005983 |
| 2024-11-0416:34 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-045026 |
| 2024-11-0416:28 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-045022 |
| 2024-08-0616:55 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035248 |
| 2024-08-0616:26 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-035229 |
| 2024-06-1316:53 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-028097 |
| 2024-05-0716:47 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-021159 |
| 2024-05-0716:22 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-021115 |
| 2024-04-2916:30 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001628280-24-019019 |
| 2024-02-2316:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001703057-24-000024 |
| 2024-02-2016:36 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001703057-24-000019 |
| 2024-02-2016:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-24-000017 |
| 2023-11-2817:28 ET | 8-K | 8.01 Other events | 0001703057-23-000047 |
| 2023-11-0216:27 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001703057-23-000040 |
| 2023-11-0216:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-23-000038 |
| 2023-10-1320:03 ET | 8-K | 8.01 Other events | 0001703057-23-000034 |
| 2023-08-0316:33 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001703057-23-000022 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.